Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients (MASTER II)

NCT00305214 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.

NCT NCT00305214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00305214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients (MASTER II)
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2003
Completion date
February 28, 2007
Enrollment
405
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, ventricular, ischemic cardiomyopathy, myocardial infarction